CVS Health (NYSE:CVS) Trading Up 0.3%

CVS Health Co. (NYSE:CVS - Get Free Report) shot up 0.3% during mid-day trading on Wednesday . The company traded as high as $57.56 and last traded at $57.51. 1,762,117 shares were traded during mid-day trading, a decline of 85% from the average session volume of 11,868,390 shares. The stock had previously closed at $57.32.

Analyst Ratings Changes

A number of research firms have recently issued reports on CVS. StockNews.com lowered shares of CVS Health from a "buy" rating to a "hold" rating in a research report on Thursday, February 15th. Barclays reduced their price target on shares of CVS Health from $78.00 to $63.00 and set an "equal weight" rating for the company in a research report on Thursday, May 2nd. UBS Group lowered shares of CVS Health from a "buy" rating to a "neutral" rating and reduced their price target for the stock from $85.00 to $60.00 in a research report on Thursday, May 2nd. TD Cowen downgraded CVS Health from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $99.00 to $59.00 in a report on Tuesday, May 7th. Finally, Bank of America dropped their price objective on CVS Health from $95.00 to $77.00 and set a "buy" rating on the stock in a report on Thursday, May 2nd. Nine equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $76.75.

CVS Health Stock Up 0.2 %

The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. The company has a market capitalization of $72.13 billion, a P/E ratio of 10.09, a PEG ratio of 0.55 and a beta of 0.56. The firm has a 50-day moving average price of $68.33 and a two-hundred day moving average price of $72.24.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). The business had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm's revenue was up 3.7% compared to the same quarter last year. During the same period in the prior year, the company posted $2.20 earnings per share. Equities research analysts anticipate that CVS Health Co. will post 7.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.63%. CVS Health's dividend payout ratio (DPR) is currently 46.75%.

Insider Buying and Selling

In other news, Director Edward J. Ludwig bought 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.24% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Bryn Mawr Capital Management LLC increased its stake in shares of CVS Health by 74.0% in the third quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator's stock valued at $3,017,000 after buying an additional 18,385 shares in the last quarter. Checchi Capital Advisers LLC increased its stake in shares of CVS Health by 2.3% in the third quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator's stock valued at $726,000 after buying an additional 233 shares in the last quarter. Personal CFO Solutions LLC increased its stake in shares of CVS Health by 2.6% in the third quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator's stock valued at $1,351,000 after buying an additional 491 shares in the last quarter. Riverpoint Wealth Management Holdings LLC acquired a new stake in shares of CVS Health in the fourth quarter valued at $218,000. Finally, Canoe Financial LP increased its stake in shares of CVS Health by 95.1% in the fourth quarter. Canoe Financial LP now owns 1,762,629 shares of the pharmacy operator's stock valued at $139,177,000 after buying an additional 859,134 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.